Longitudinal change in ultrasound-derived rectus femoris cross-sectional area in COPD [0.03%]
慢性阻塞性肺疾病患者股四头肌超声测定的横截面积纵向变化
Timothy O Jenkins,Suhani Patel,George D Edwards et al.
Timothy O Jenkins et al.
Background: Skeletal muscle dysfunction is common in COPD. Ultrasound-derived rectus femoris cross-sectional area (RFCSA) is a radiation free, non-invasive measure of muscle bulk that relates to quadriceps strength in peo...
Diagnostic value of the pepsin concentration in saliva and induced sputum for gastroesophageal reflux-induced chronic cough: a prospective clinical study [0.03%]
唾液及咳出物中胃蛋白酶浓度对胃食管反流病所致慢性咳嗽诊断价值的临床研究
Wenhua Gu,Wei Chen,Tongyangzi Zhang et al.
Wenhua Gu et al.
Background: Finding a simple, effective and rapid diagnostic method to improve the diagnosis of gastroesophageal reflux-induced chronic cough (GERC) is indicated. Our objective was to determine the diagnostic value of the...
A survey of UK respiratory specialists' opinion on the management of chronic cough [0.03%]
英国呼吸系统专家对慢性咳嗽管理意见的调查研究
Alyn Morice
Alyn Morice
Chronic cough is a common presentation to respiratory specialists. Here, we survey their opinion on diagnosis, investigation and management. Whilst investigations were appropriate, treatments were not guideline-based. Further education is n...
Comprehensive geriatric assessment for people with both COPD and frailty starting pulmonary rehabilitation: a mixed-methods feasibility trial [0.03%]
综合评估伴有慢性阻塞性肺疾病和衰老虚弱的患者进行康复治疗的可能性试验：一种混合方法试验
Lisa Jane Brighton,Catherine J Evans,Morag Farquhar et al.
Lisa Jane Brighton et al.
Introduction: Many people with COPD experience frailty. Frailty increases risk of poor health outcomes, including non-completion of pulmonary rehabilitation. Integrated approaches to support people with COPD and frailty t...
Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo [0.03%]
美泊利单抗和安慰剂治疗重度嗜酸性粒细胞性哮喘急性加重的临床特征分析
Imran Howell,Daniel J Bratton,Gareth Hynes et al.
Imran Howell et al.
Asthma exacerbations in people treated with mepolizumab result in less peak expiratory flow reduction than placebo but similar symptom scores. Symptoms recover slower, indicating these exacerbations may be less prednisolone responsive. http...
Pulmonary perfusion defects or residual vascular obstruction and persistent symptoms after pulmonary embolism: a systematic review and meta-analysis [0.03%]
肺栓塞后的肺通气/灌注显像缺陷或血管阻塞持续存在与症状持续存在之间的关系：系统评价和汇总分析
Ludovica Anna Cimini,Dieuwke Luijten,Stefano Barco et al.
Ludovica Anna Cimini et al.
Introduction: Up to 50% of pulmonary embolism (PE) patients have perfusion defects or residual vascular obstruction during follow-up despite adequate anticoagulant treatment, and a similar percentage experience chronic fu...
Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID [0.03%]
基于运动的长期COVID患者康复计划对疲劳症状变化的影响
Enya Daynes,Molly M Baldwin,Matthew Annals et al.
Enya Daynes et al.
Background: There is evidence to support COVID-19 rehabilitation programmes improving persistent COVID-19 symptoms; however, there is concern that therapies that include an exercise component may increase fatigue and post...
Time to negative conversion and cardiopulmonary performance in athletes with COVID-19 [0.03%]
运动员新冠病毒肺炎的转阴时间及心肺功能恢复情况
Pasquale Mone,Leonardo Bencivenga,Gaetano Santulli et al.
Pasquale Mone et al.
Athletes with longer time to negative conversion for COVID-19 do not present reduction of exercise capacity. However, respiratory and ventilatory parameters are modified. https://bit.ly/3TMdrFL. ...
Physical capacity and inactivity in obstructive airway diseases: a "can do, do do" analysis [0.03%]
支气管疾病患者的体能与不活动现状："能够做到，但不去做" 分析
Paola D Urroz Guerrero,Hayley Lewthwaite,Peter G Gibson et al.
Paola D Urroz Guerrero et al.
Introduction: Physical capacity is an important determinant of physical activity in people with obstructive airway disease (OAD). This study aimed to extend the "can do, do do" concept in people with OAD, to identify if p...
Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial [0.03%]
特发性肺纤维化进展的循环生物标志物：来自INMARK试验的数据
Toby M Maher,R Gisli Jenkins,Vincent Cottin et al.
Toby M Maher et al.
Background: We used data from the INMARK trial to investigate associations between circulating biomarkers of extracellular matrix (ECM) turnover, inflammation and epithelial dysfunction and disease progression in subjects...